Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

Crossref logo

Fol. Biol. 2004, 50, 24-28

https://doi.org/10.14712/fb2004050010024

The Alterations of Immunological Reactivity in Heroin Addicts and Their Normalization in Patients Maintained on Methadone

Alena Zajícová1,2, H. Wilczek3, V. Holáň1,2

1Faculty of Science, Charles University, Prague, Czech Republic
2Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic
33rd Medical Clinic, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

Received December 2003
Accepted December 2003

References

1. Bayer, B. M., Gastonguay, M. R., Hernandez, M. C. (1992) Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology 23, 117-124. <https://doi.org/10.1016/0162-3109(92)90035-B>
2. Bryant, H. U., Bernton, E. W., Holaday, J. W. (1987) Immunosuppressive effects of chronic morphine treatment in mice. Life Sci. 41, 1731-1738. <https://doi.org/10.1016/0024-3205(87)90601-1>
3. Beilin, B., Shavit, Y., Trabekin, E., Mordashev, B., Mayburd, E., Zeidel, A. (2003) The effect of postoperative pain management on immune response to surgery. Anesth. Analg. 97, 822-827. <https://doi.org/10.1213/01.ANE.0000078586.82810.3B>
4. Bossong, H., Scheerer, S. (1989) Metadon-Behandlung in der Bundesrepublik. In: Drugs and Drug-policy, eds. Scheerer, S., Vogt, I., pp. 333-345, Campus, Frankfurt/New York.
5. Brugo, M. A., Guffanti, A., Guzzetti, S., Pedretti, D., Stringhetti, M., Confalonieri, F. (1983) Difference in the behavior of T-lymphocyte populations in heroin and methadone addicts. Boll. Ist. Sieroter Milan 62, 517-523.
6. Eisenstein, T. K., Hilburger, M. E. (1998) Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J. Neuroimmunol. 83, 36-44. <https://doi.org/10.1016/S0165-5728(97)00219-1>
7. Fecho, K., Maslonek, K. A., Dykstra, L. A., Lysle, D. T. (1996) Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 277, 633-645. <https://doi.org/10.1016/S0022-3565(25)12916-9>
8. Govitrapong, P., Sittitum, T., Kotchabhakdi, N., Uneklabh, T. (1998) Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J. Pharmacol. Exp. Ther. 286, 883-889. <https://doi.org/10.1016/S0022-3565(24)37665-7>
9. Holáň, V., Zajícová, A., Krulová, M., Blahoutová, V., Wilczek, H. (2003) Augmented production of proinflammatory cytokines and accelerated allotransplantation reactions in heroin-treated mice. Clin. Exp. Immunol. 132, 40-45. <https://doi.org/10.1046/j.1365-2249.2003.02103.x>
10. Houghtling, R. A., Mellon, R. D., Tan, R. J., Bayer, B. M. (2000) Acute effects of morphine on blood lymphocyte proliferation and plasma IL-6 levels. Ann. N Y Acad. Sci. 917, 771-777. <https://doi.org/10.1111/j.1749-6632.2000.tb05442.x>
11. Kim, M. H., Hahm, T. S. (2001) Plasma levels of interleukin6 and interleukin-10 are affected by ketorolac as an adjuct to patient-controlled morphine after abdominal hysterectomy. Clin. J. Pain. 17, 72-77. <https://doi.org/10.1097/00002508-200103000-00010>
12. Kreek, M. J., Koob, G. F. (1998) Drug dependency. Drug Alc. Dep. 51, 23-47. <https://doi.org/10.1016/S0376-8716(98)00064-7>
13. Louria, D. B., Hensle, T., Rose, J. (1967) The major medical complications of heroin addiction. Ann. Intern. Med. 67, 1-22. <https://doi.org/10.7326/0003-4819-67-1-1>
14. Lysle, D. T., Coussons, M. E., Watts, V. J., Bennett, E. H., Dykstra, L. A. (1993) Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 265, 1071-1078. <https://doi.org/10.1016/S0022-3565(25)38224-8>
15. McFarlane, A. S., Peng, X., Meissler, J. J. Jr., Rogers, T. J., Geller, E. B., Adler, W. W., Eisenstein, T. K. (2000) Morphine increases susceptibility to oral Salmonella typhimurium infection. J. Infect. Dis. 181, 1350-1358. <https://doi.org/10.1086/315403>
16. McLachlan, C., Crofts, N., Wodak, A., Crowe, S. (1993) The effects of methadone on immune function among injecting drug users: a review. Addiction 88, 257-263. <https://doi.org/10.1111/j.1360-0443.1993.tb00809.x>
17. Nelson, C. J., Schneider, G. M., Lysle, D. T. (2000) Involvement of central mubut not deltaor kappaopioid receptors in immunomodulation. Brain Behav. Immun. 14, 170-184. <https://doi.org/10.1006/brbi.1999.0575>
18. Nelson, C. J., Lysle, D. T. (2001) Morphine modulation of the contact hypersensitivity response: characterization of immunological changes. Clin. Immunol. 98, 370-377. <https://doi.org/10.1006/clim.2000.4995>
19. Novick, D. M., Ochshorn, M., Ghali, V., Croxson, T. S., Mercev, W. D., Chiorazzi, N., Kreek, M. J. (1989) Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J. Pharmacol. Exp. Ther. 250, 606-610. <https://doi.org/10.1016/S0022-3565(25)22252-2>
20. Pacifici, R., Di Carlo, S., Bacosi, A., Pichini, S., Zuccaro, P. (2000) Pharmacokinetics and cytokine production in heroin and morphine-treated mice. Int. J. Immunopharmacol. 22, 603-614. <https://doi.org/10.1016/S0192-0561(00)00023-0>
21. Payte, J. T. A. (1991) Brief history of methadone in the treatment of opioid dependence. A personal perspective. J. Psychoactive Drugs 23, 103-107. <https://doi.org/10.1080/02791072.1991.10472226>
22. Peng, X., Zhou, W., Cao, D., Liu, C., Li, Z. (1999) Changes and significance of natural killer cells, IL-2, IL-6 and TNF-α in heroin addicts after detoxification. Hua Xi Yi Ke Da Xue Xue Bao 30, 449-451. (in Chinese)
23. Peng, X., Mosser, D., Adler, M. W., Rogers, T. J., Meisser, J. J., Eisenstein, T. K. (2000) Morphine enhances interleukin-12 and the production of pro-inflammatory cytokines in mouse peritoneal macrophages. J. Leukoc. Biol. 68, 723-728. <https://doi.org/10.1189/jlb.68.5.723>
24. Peterson, P. K., Molitor, T. W., Chao, C. C. (1998) The opioid-cytokine connection. J. Neuroimmunol. 83, 63-69. <https://doi.org/10.1016/S0165-5728(97)00222-1>
25. Roy, S., Cain, K. J., Chapin, R. B., Charboneau, R. G., Barke, R. A. (1998) Morphine modulated NF kappa B activation in macrophages. Biochem. Biophys. Res. Commun. 245, 392-396. <https://doi.org/10.1006/bbrc.1998.8415>
26. Stefano, G. B. (1996) Opioid and opiate immunoregulatory processes. Crit. Rev. Immunol. 16, 109-144. <https://doi.org/10.1615/CritRevImmunol.v16.i2.10>
27. Zagon, I. S., McLaughlin, P. J. (1981) Heroin prolongs survival time and retards tumor growth in mice with neuroblastoma. Brain Res. Bull. 7, 25-32. <https://doi.org/10.1016/0361-9230(81)90094-0>
28. Zubelewicz, B., Braczkowski, R., Renshaw, D., Harbuz, M. S. (1999) Central injection of morphine stimulates plasma corticosterone and interleukin (IL)-6 and Il-6 R mRNAs in the pituitary and adrenals in adjuvant-induced arthitis. J. Biol. Regul. Homeost. Agents 13, 103-109.
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive